tiprankstipranks
NeuroPace reports sees Q4 revenue $21M-$21.5M, consensus $20.91M
PremiumThe FlyNeuroPace reports sees Q4 revenue $21M-$21.5M, consensus $20.91M
14d ago
NeuroPace narrows FY24 revenue view to $79.4M-$79.9M from $78M-$80M
Premium
The Fly
NeuroPace narrows FY24 revenue view to $79.4M-$79.9M from $78M-$80M
14d ago
NeuroPace price target raised to $14 from $9 at JPMorgan
Premium
The Fly
NeuroPace price target raised to $14 from $9 at JPMorgan
1M ago
NeuroPace raises FY24 revenue view to $78M-$80M from $76M-$78M
PremiumThe FlyNeuroPace raises FY24 revenue view to $78M-$80M from $76M-$78M
2M ago
NPCE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
NPCE Upcoming Earnings Report: What to Expect?
2M ago
NeuroPace submits safety, effectiveness data from RNS System study to FDA
Premium
The Fly
NeuroPace submits safety, effectiveness data from RNS System study to FDA
3M ago
NeuroPace price target lowered to $8 from $9.50 at Morgan Stanley
PremiumThe FlyNeuroPace price target lowered to $8 from $9.50 at Morgan Stanley
6M ago
Lake Street highlights five ‘bargain bin’ small cap healthcare ideas for 2H
Premium
The Fly
Lake Street highlights five ‘bargain bin’ small cap healthcare ideas for 2H
7M ago
NeuroPace post Q1 move ‘overdone,’ says Lake Street
Premium
The Fly
NeuroPace post Q1 move ‘overdone,’ says Lake Street
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100